CIK 0001094038 · Non-accelerated filer<br>Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880277072
- Phone
- (713) 400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale
- 424B5 Offering Prospectus
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale
- SC 13G Stake Amended Statement of Ownership
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 8-K Event Auditor change
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 8-K Event Material agreement · Unregistered share sale
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 8-K Event Other events
- S-3/A Offering Registration Statement
- 10-Q/A Report 10-Q/A
Page 28 of 46 · 904 filings